About this Event
Virtual Event
This presentation includes a review and discussion of Warning Letters for Principal Investigators (Clinical Investigators), Sponsor-Investigators and Institutional Review Boards, issued by the FDA. Recent examples of Warning Letters will be analyzed and causes, significance, and consequences of Warning Letters will be discussed.
Event Details
See Who Is Interested
3 people are interested in this event
User Activity
No recent activity
